藤城緑

フジシロミドリ | FUJISHIRO Midori

所属機関・部署：
職名：准教授

研究分野 (1件)：代謝、内分泌学

競争的資金等の研究課題 (12件)：

2020 - 2023 肥満2型糖尿病のインスリン分泌および作用障害におけるXORの役割の解明
2017 - 2020 遺伝子発現修飾膵β細胞株の大規模作製とオミクス解析によるインスリン分泌機構の解明
2014 - 2017 プロリン異性化酵素Pin1,PAR14と含有複合体による代謝調節と治療への展開
2014 - 2016 近位筋優位遺伝性運動感覚ニューロパチー原因遺伝子産物の発現調節と代謝異常への関与
2012 - 2015 2型糖尿病における運動による炎症性シグナル改善機序の解明

全件表示

論文 (129件)：

Takeshi Yamamotoya, Yukino Ohata, Yasuyuki Akasaka, Shun Hasei, Masa-Ki Inoue, Yusuke Nakatsu, Machi Kanna, Hiroki Yamazaki, Akifumi Kushiyama, Midori Fujishiro, et al. Trk-fused gene plays a critical role in diet-induced adipose tissue expansion and is also involved in thyroid hormone action. PNAS nexus. 2024. 3. 4. pgae150
Yasuyuki Akasaka, Shun Hasei, Yukino Ohata, Machi Kanna, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Akifumi Kushiyama, Hiraku Ono, Akio Matsubara, et al. Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells. International journal of molecular sciences. 2023. 24. 21
Ogawa K, Akimoto T, Hara M, Fujishiro M, Nakajima H. Clinical study of 16 patients with thalamic infarction. Neurology and Clinical Neuroscience. 2023
Machi Kanna, Yusuke Nakatsu, Takeshi Yamamotoya, Akifumi Kushiyama, Midori Fujishiro, Hideyuki Sakoda, Hiraku Ono, Koji Arihiro, Tomoichiro Asano. Hepatic Pin1 Expression, Particularly in Nuclei, Is Increased in NASH Patients in Accordance with Evidence of the Role of Pin1 in Lipid Accumulation Shown in Hepatoma Cell Lines. International Journal of Molecular Sciences. 2023. 24. 10. 8847-8847
Midori Fujishiro, Sho Tanaka, Kentaro Watanabe, Kazuhiro Imatake, Yasuyuki Suzuki, Hisamitsu Ishihara, Shigemasa Tani. Association of Glycated Hemoglobin Level with Self-Reported Chewing Problems in Elderly Community-Dwelling Individuals in Japan. Journal of Multidisciplinary Healthcare. 2023. 2023. 16. 1231-1238

MISC (37件)：

Takako Kikuchi, Akifumi Kushiyama, Midori Fujishiro, Hideyuki Sakoda, Tomoichiro Asano, Yasuhiko Iwamoto. Mechanism Mediated by S6 Kinase Resulting in both Sufficient Glucose Metabolism Improvement and Insufficient Weight Loss by Glucose Excretion against Fat Load. DIABETES. 2018. 67
Akifumi Kushiyama, Takako Kikuchi, Hiroki Yamazaki, Takeshi Yamamotoya, Hideyuki Sakoda, Midori Fujishiro, Yusuke Nakatsu, Akiyoshi Uemura, Takashi Shirakura, Tomoichiro Asano, et al. Role of Xanthine Oxidoreductase from Mesenchymal Cells in Retinal Inflammation after Pericyte Breakdown. DIABETES. 2018. 67
Midori Fujishiro, Akifumi Kushiyama, Hiroki Yamazaki, Takeshi Yamamotoya, Takako Kikuchi, Hideyuki Sakoda, Ryo Suzuki, Takashi Kadowaki. The Prevalence of Gastrointestinal Symptoms Depends on Disease Duration and Gastrointestinal Tract Region in Patients with Type 2 Diabetes. DIABETES. 2018. 67
Midori Fujishiro, Yusuke Nakatsu, Hideyuki Sakoda, Akifumi Kushiyama, Tomoichiro Asano. SGLT2 Inhibitor Luseogliflozin Improves Nonalcoholic Hepatosteatosis in a Rodent Model. DIABETES. 2015. 64. A721-A721
Yusuke Nakatsu, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Aya Katasako, Keiichi Mori, Yasuka Matsunaga, Tomoichiro Asano. The Xanthine Oxidase Inhibitor Febuxostat Suppresses Nonalcoholic Steatohepatitis Development due to High-Fat Diet Containing Trans Fatty Acid. DIABETES. 2015. 64. A717-A717

学歴 (2件)：

1997 - 2001 東京大学医学部内科学
1989 - 1995 九州大学医学部医学科

学位 (1件)：

医学博士 (東京大学)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

藤城 緑

藤城緑